Debt-to-equity of ADC Therapeutics SA from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ADC Therapeutics SA quarterly Debt-to-equity in % history and change rate from 30 Sep 2023 to 30 Sep 2025.
  • ADC Therapeutics SA Debt-to-equity for the quarter ending 30 Sep 2025 was -237%, a 24% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ADC Therapeutics SA Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -237% +77% +24% 30 Sep 2025
Q2 2025 -256% +121% +32% 30 Jun 2025
Q1 2025 -277% +202% +42% 31 Mar 2025
Q4 2024 -293% +674% +70% 31 Dec 2024
Q3 2024 -314% -8284% -104% 30 Sep 2024
Q2 2024 -377% 30 Jun 2024
Q1 2024 -479% 31 Mar 2024
Q4 2023 -967% 31 Dec 2023
Q3 2023 7970% 30 Sep 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.